Production (Stage)
BioAtla, Inc.
BCAB
$0.391
$0.00140.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.02% | -40.60% | 49.76% | 9.31% | 13.71% |
| Total Depreciation and Amortization | -19.74% | 0.00% | -0.44% | -4.58% | -34.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -120.91% | -48.77% | -12.10% | 8.52% | -16.06% |
| Change in Net Operating Assets | 72.25% | -207.22% | 458.39% | 91.65% | -66.00% |
| Cash from Operations | 2.95% | -227.03% | 73.26% | 37.74% | -3.03% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | 26.32% | -46.15% | 56.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -104.24% | 66,621.43% | -106.22% | 1,830.77% | -110.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.33% | -45.16% | 72.87% | 38.50% | -3.46% |